GBI Research Market Research Reports

TITLE Actions
Optic Nerve Disorders Drug Development Pipeline Review, 2018
Published in Oct 2018 | US $ 3995 Onwards | By GBI Research

Optic Nerve Disorders Drug Development Pipeline Review, 2018 Summary This report provides an overview of the pipeline landscape for disorders of the optic nerve, the bundle of nerve fibers that transmits visual information f...

Hereditary Hematological Disorders Drug Development Pipeline Review, 2018
Published in Oct 2018 | US $ 3995 Onwards | By GBI Research

Hereditary Hematological Disorders Drug Development Pipeline Review, 2018 Summary This report provides an overview of the pipeline landscape for hereditary hematological disorders. It provides comprehensive information on th...

Frontier Pharma: Orphan and Rare Dermatological Diseases - First-in-Class Therapies Demonstrate Potential Disease-Modifying Effects in Areas of High Unmet Need Such as Epidermolysis Bullosa
Published in Oct 2018 | US $ 6995 Onwards | By GBI Research

Orphan and rare dermatological diseases are considerably diverse in terms of pathophysiology, clinical presentation and disease severity. Many of these conditions are extremely debilitating and can even be life-threatening in some cases. D...

Dermatological Burns, Scars and Ulcers Drug Development Pipeline Review, 2018
Published in Sep 2018 | US $ 3995 Onwards | By GBI Research

This report provides an overview of the pipeline landscape for dermatological burns, scars and ulcers. It provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for pressure ulc...

Pain Drug Development Pipeline Review, 2018
Published in Sep 2018 | US $ 3995 Onwards | By GBI Research

This report provides an overview of the pipeline landscape for pain disorders. It provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for post-operative pain, fibromyalgia, c...

Depression and Anxiety Disorders Drug Development Pipeline Review, 2018
Published in Sep 2018 | US $ 3995 Onwards | By GBI Research

Depression and Anxiety Disorders Drug Development Pipeline Review, 2018 Summary This report provides an overview of the pipeline landscape for depression and anxiety disorders. It provides comprehensive information on th...

Global Orphan and Rare Dermatology Drugs Market to 2024 - An Increasingly Competitive Landscape as New Companies Enter the Market with Novel Products, Driving Strong Market Growth
Published in Sep 2018 | US $ 4995 Onwards | By GBI Research

Global Orphan and Rare Dermatology Drugs Market to 2024 - An Increasingly Competitive Landscape as New Companies Enter the Market with Novel Products, Driving Strong Market Growth Summary Dermatology is a highly diverse ...

Heart Failure Therapeutics in Asia-Pacific Markets to 2024 - Growth Driven by Rising Geriatric Population and Increasing Uptake of Recently Launched Therapy
Published in Sep 2018 | US $ 4995 Onwards | By GBI Research

Heart Failure Therapeutics in Asia-Pacific Markets to 2024 - Growth Driven by Rising Geriatric Population and Increasing Uptake of Recently Launched Therapy Summary Heart failure (HF) is a life-threatening syndrome with ...

Blood Pressure Disorders Drug Development Pipeline Review, 2018
Published in Aug 2018 | US $ 3995 Onwards | By GBI Research

Blood Pressure Disorders Drug Development Pipeline Review, 2018 Summary This report provides an overview of the pipeline landscape for blood pressure disorders. It provides comprehensive information on the therapeutics under...

Pancreatic and Bile Duct Cancer Drug Development Pipeline Review, 2018
Published in Aug 2018 | US $ 3995 Onwards | By GBI Research

Pancreatic and Bile Duct Cancer Drug Development Pipeline Review, 2018 Summary This report provides an overview of the pipeline landscape for pancreatic and bile duct cancer. It provides comprehensive information on the ther...

Osteoporosis Therapeutics in Asia-Pacific Markets to 2024 - Growth Driven by ongoing Transition from Anti-resorptive Agents to Anabolic Therapies, Rising Prevalence, and Growing Awareness
Published in Aug 2018 | US $ 4995 Onwards | By GBI Research

Summary Osteoporosis is a “silent epidemic” and as per the WHO declarations, it is a priority health issue. Osteoporosis is a disruption of bone architecture and decrease in bone mass, leading to a number of co...

Respiratory Tract Infections Drug Development Pipeline Review, 2018
Published in Jul 2018 | US $ 3995 Onwards | By GBI Research

Respiratory Tract Infections Drug Development Pipeline Review, 2018 Summary This report provides an overview of the pipeline landscape for respiratory tract infections. It provides comprehensive information on the therapeuti...

Mucopolysaccharidosis Disorders Drug Development Pipeline Review, 2018
Published in Jul 2018 | US $ 3995 Onwards | By GBI Research

Mucopolysaccharidosis Disorders Drug Development Pipeline Review, 2018 Summary This report provides an overview of the pipeline landscape for mucopolysaccharidosis disorders, a group of inherited lysosomal storage disorders....

Diarrhea and Constipation Drug Development Pipeline Review, 2018
Published in Jul 2018 | US $ 3995 Onwards | By GBI Research

Diarrhea and Constipation Drug Development Pipeline Review, 2018 Summary This report provides an overview of the pipeline landscape for diarrhea and constipation. It provides comprehensive information on the therapeutics und...

Frontier Pharma: Breast Cancer - First-in-Class Innovation Underlies Immunotherapeutic Potential and Pipeline Diversification for Late-Stage Breast Cancer
Published in Jul 2018 | US $ 6995 Onwards | By GBI Research

Frontier Pharma: Breast Cancer - First-in-Class Innovation Underlies Immunotherapeutic Potential and Pipeline Diversification for Late-Stage Breast Cancer Summary Breast cancer remains a major global healthcare concern despi...

Global Cancer Immunotherapies Market to 2024 - Increased Uptake of Immune Checkpoint Inhibitors Driving Growth, Supported by a Large, Robust Pipeline
Published in Jul 2018 | US $ 4995 Onwards | By GBI Research

Global Cancer Immunotherapies Market to 2024 - Increased Uptake of Immune Checkpoint Inhibitors Driving Growth, Supported by a Large, Robust Pipeline Summary Cancer immunotherapy, which can predominantly be classed as a form...

Colorectal Cancer Therapeutics in Asia-Pacific Markets to 2024 - Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market
Published in Jul 2018 | US $ 4995 Onwards | By GBI Research

Colorectal cancer (CRC) is the most common cancer and the leading cause of cancer-related mortality globally. The five-year prevalence population for CRC in Asia-Pacific was 1.7 million in 2017. This figure has been gradually rising with the growi...

Diabetes and Associated Metabolic Conditions Drug Development Pipeline Review, 2018
Published in Jun 2018 | US $ 3995 Onwards | By GBI Research

Diabetes and Associated Metabolic Conditions Drug Development Pipeline Review, 2018 Summary This report provides an overview of the pipeline landscape for diabetes and associated metabolic conditions. It provides comprehensi...

Menopausal Disorders Drug Development Pipeline Review, 2018
Published in Jun 2018 | US $ 3995 Onwards | By GBI Research

Menopausal Disorders Drug Development Pipeline Review, 2018 Summary This report provides an overview of the pipeline landscape for menopausal disorders. It provides comprehensive information on the therapeutics under develop...

Hepatitis Drug Development Pipeline Review, 2018
Published in Jun 2018 | US $ 3995 Onwards | By GBI Research

Hepatitis Drug Development Pipeline Review, 2018 Summary This report provides an overview of the pipeline landscape for hepatitis infections. It provides comprehensive information on the therapeutics under development and ke...

We are on:

Need Help?